Jun 30
|
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
|
Jun 27
|
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
|
Jun 26
|
Why This Weight Loss Drug Company's Stock Surged Today
|
Jun 26
|
Viking commences Phase III clinical programme of VK2735 for obesity
|
Jun 26
|
VKTX Initiates Phase 3 Study on Obesity Candidate VK2735
|
Jun 26
|
3 Growth Stocks I'm Loading Up On
|
Jun 21
|
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
|
Jun 20
|
Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
|
Jun 18
|
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
|
Jun 16
|
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
|
Jun 16
|
Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?
|
May 22
|
Better Weight Loss Stock: Amgen or Viking Therapeutics?
|
May 16
|
Why Viking Therapeutics Stock Bumped 3% Higher Today
|
May 16
|
Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
|
Mar 13
|
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
|
Mar 13
|
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?
|
Mar 13
|
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
|
Mar 13
|
Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?
|
Mar 12
|
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
|
Mar 12
|
B. Riley sees two key positives in Viking manufacturing agreement
|